Cydar Medical

Cydar Medical is a United Kingdom-based startup founded in 2014, specializing in AI, Big Data, Computing, Health Care, and Medical Devices. The company's slogan "Simply Powering Progress" reflects its mission to transform image-guided endovascular surgery using cloud-based AI and data fusion, enabling clinical teams to make faster, more informed decisions.

Through its end-to-end solution, Cydar Medical aims to improve surgical accuracy by providing real-time data-driven insights to support decision-making, thereby mitigating risks and enhancing surgical planning. The company's focus on enhancing patient outcomes aligns with the broader goal of shaping the future of surgery through impactful technology.

The latest significant development for Cydar Medical is the £9.30M Series A investment secured on 13 February 2023 from investors Pembroke VCT and Downing LLP. This investment not only validates the company's potential but also signifies investor confidence in its innovative approach.

By leveraging AI and data-driven insights, Cydar Medical not only aims to elevate surgical standards but also seeks to contribute to the economic health of healthcare providers. The ability to reduce the cost of care without compromising quality presents a compelling value proposition, offering the potential for improved patient outcomes and new opportunities for revenue growth for hospitals.

As Cydar Medical continues to advance its technology and expand its impact, the company remains focused on its simple yet powerful goal of making a measurable difference in the field of surgery, ultimately underpinning the future of healthcare.